STAT3 - signal transducer and activator of transcription 3 Gene
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 574128
About STAT3
Primary_assembly 16: 53,440,779-53,524,629 reverse strand.Mmul_10:CM014351.1
This gene has 3 transcripts (splice variants), 133 orthologues and 6 paralogues.
STAT3 Products (13)
| mRNA | Protein | Name |
|---|---|---|
| XM_028836496.1 | XP_028692329.1 | signal transducer and activator of transcription 3 isoform X6 |
| XM_028836497.1 | XP_028692330.1 | signal transducer and activator of transcription 3 isoform X7 |
| XM_028836498.1 | XP_028692331.1 | signal transducer and activator of transcription 3 isoform X8 |
| XM_028836501.1 | XP_028692334.1 | signal transducer and activator of transcription 3 isoform X11 |
| XM_028836500.1 | XP_028692333.1 | signal transducer and activator of transcription 3 isoform X10 |
| XM_028836492.1 | XP_028692325.1 | signal transducer and activator of transcription 3 isoform X2 |
| XM_028836502.1 | XP_028692335.1 | signal transducer and activator of transcription 3 isoform X12 |
| XM_028836493.1 | XP_028692326.1 | signal transducer and activator of transcription 3 isoform X3 |
| XM_028836491.1 | XP_028692324.1 | signal transducer and activator of transcription 3 isoform X1 |
| XM_028836495.1 | XP_028692328.1 | signal transducer and activator of transcription 3 isoform X5 |
| XM_028836494.1 | XP_028692327.1 | signal transducer and activator of transcription 3 isoform X4 |
| XM_028836503.1 | XP_028692336.1 | signal transducer and activator of transcription 3 isoform X13 |
| XM_028836499.1 | XP_028692332.1 | signal transducer and activator of transcription 3 isoform X9 |
STAT3 Protein Structure
STAT_int
STAT_int: smart00964 (96 - 214)
STAT3_CCD
STAT3_CCD: cd16853 (233 - 421)
STAT3_DBD
STAT3_DBD: cd16847 (424 - 587)
SH2_STAT3
SH2_STAT3: cd10374 (657 - 818)
- 0
- 200
- 400
- 600
- 800
- 874 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
signal transducer and activator of transcription 3 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(22)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10201 | Sorafenib | Inhibitor | 99.85% | Yes |
| HY-117287 | Deucravacitinib | Inhibitor | 99.93% | Unkown |
| HY-N0193 | Artesunate | Inhibitor | 99.89% | Yes |
| HY-14944 | Homoharringtonine | Inhibitor | 99.96% | Yes |
| HY-B0497 | Niclosamide | Inhibitor | 99.96% | Yes |
| HY-100754 | Ritlecitinib | Inhibitor | 99.80% | Yes |
| HY-B2163 | Astaxanthin | Inhibitor | 98.0% | Unkown |
| HY-12987 | Pimozide | Inhibitor | 99.94% | Yes |
| HY-10201A | Sorafenib tosylate | Inhibitor | 99.98% | Yes |
| HY-B0130 | Perindopril | 99.85% | Yes | |
| HY-17015A | Peramivir | 99.94% | Unkown | |
| HY-B1436 | Nifuroxazide | Inhibitor | 99.90% | Unkown |
| HY-B0294 | Flubendazole | Inhibitor | 99.05% | Yes |
| HY-15728 | Radotinib | Inhibitor | 99.19% | Yes |
| HY-B0130A | Perindopril erbumine | 99.98% | Yes | |
| HY-B0667 | Balsalazide | Inhibitor | 98.65% | Yes |
| HY-B0667A | Balsalazide sodium hydrate | Inhibitor | 98.30% | Yes |
| HY-100754C | Ritlecitinib tosylate | Inhibitor | 99.65% | Yes |
| HY-112961 | Patiromer | Inhibitor | 95.0% | Unkown |
| HY-B0497B | Niclosamide monohydrate | Inhibitor | / | Unkown |
| HY-100754A | Ritlecitinib malonate | Inhibitor | / | Unkown |
| HY-108244 | Balsalazide disodium | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P9916 | Sarilumab | Inhibitor | 99.36% | Unkown |
| HY-P99118 | Serplulimab | Inducer | 99.30% | Unkown |
Clinical Phase
Bioactive Molecules
(18)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-12987S | Pimozide-d4 | Inhibitor | 99.2% | Phase 4 |
| HY-16141 | Cilengitide | Inhibitor | 99.91% | Phase 3 |
| HY-13919 | Napabucasin | Inhibitor | 99.94% | Phase 3 |
| HY-113066C | Guanosine 5'-diphosphate sodium, 96% (HPLC) | Inhibitor | 99.88% | Phase 3 |
| HY-109038 | Mocravimod | Activator | 98.39% | Phase 3 |
| HY-113066 | Guanosine 5'-diphosphate | Inhibitor | / | Phase 3 |
| HY-112288 | C188-9 | Inhibitor | 99.84% | Phase 2 |
| HY-15312 | WP1066 | Inhibitor | 99.53% | Phase 2 |
| HY-136657 | SC-43 | Inhibitor | 99.01% | Phase 2 |
| HY-14743B | Golotimod hydrochloride | Inhibitor | 99.79% | Phase 2 |
| HY-14743 | Golotimod | Inhibitor | 98.98% | Phase 2 |
| HY-14743A | Golotimod TFA | Inhibitor | / | Phase 2 |
| HY-156730 | KT-333 | Degrader | 98.91% | Phase 1 |
| HY-13326 | ASP3026 | 99.88% | Phase 1 | |
| HY-16196 | ENMD-1198 | Inhibitor | 98.87% | Phase 1 |
| HY-156730A | KT-333 ammonium | Degrader | 99.48% | Phase 1 |
| HY-156730B | KT-333 diammonium | Degrader | / | Phase 1 |
| HY-124067 | EC-70124 | Inhibitor | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99210 | Olokizumab | Inhibitor | 99.54% | Phase 3 |
| HY-P99244 | Fezakinumab | Modulator | 99.9% | Phase 2 |
| HY-P991888 | INCA033989 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(227)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13818 | Stattic | Inhibitor | 99.96% | Unkown |
| HY-107632 | GYY4137 | Inhibitor | 98.64% | Unkown |
| HY-12000 | AG490 | Inhibitor | 99.86% | Unkown |
| HY-P1061 | Colivelin | Activator | 99.92% | Unkown |
| HY-10074 | TPCA-1 | Inhibitor | 99.66% | Unkown |
| HY-15146 | NSC 74859 | Inhibitor | 98.35% | Unkown |
| HY-N0751 | Scutellarin | Inhibitor | 99.57% | Unkown |
| HY-N0174 | Cryptotanshinone | Inhibitor | 99.07% | Unkown |
| HY-148748 | Butyzamide | Activator | 99.83% | Unkown |
| HY-129602 | SD-36 | Inhibitor | 99.73% | Unkown |
| HY-N0177 | Diosgenin | Inhibitor | 99.92% | Unkown |
| HY-N0250 | Saikosaponin D | Inhibitor | 99.81% | Unkown |
| HY-125771 | 1-Stearoyl-sn-glycero-3-phosphocholine | Inhibitor | 99.53% | Unkown |
| HY-P1061A | Colivelin TFA | Activator | 99.79% | Unkown |
| HY-111152 | ML115 | Agonist | 99.98% | Unkown |
| HY-N0622 | Morusin | Inhibitor | 99.54% | Unkown |
| HY-129603 | SI-109 | Inhibitor | 99.91% | Unkown |
| HY-16975 | SH-4-54 | Inhibitor | 99.80% | Unkown |
| HY-N1405 | Cucurbitacin I | Inhibitor | 99.60% | Unkown |
| HY-100493 | BP-1-102 | Inhibitor | 99.26% | Unkown |
| HY-100753 | STAT3-IN-1 | Inhibitor | 96.28% | Unkown |
| HY-115594 | Erasin | Inhibitor | 96.02% | Unkown |
| HY-N0038 | Alantolactone | Inhibitor | 99.94% | Unkown |
| HY-173236 | STAT4-IN-1 | Inhibitor | 99.17% | Unkown |
| HY-N0202 | Atractylenolide II | Inhibitor | 99.89% | Unkown |
| HY-170621 | STAT1/3-IN-1 | Inhibitor | 99.23% | Unkown |
| HY-128588 | STAT3-IN-3 | Inhibitor | 98.40% | Unkown |
| HY-N2959 | Brevilin A | Inhibitor | 99.86% | Unkown |
| HY-N0826 | Corynoline | Modulator | 98.84% | Unkown |
| HY-113205 | 15-keto-Prostaglandin E2 | Inhibitor | ≥99.0% | Unkown |
| HY-19536 | LLL12 | Inhibitor | 99.45% | Unkown |
| HY-160496 | STAT3-IN-25 | Inhibitor | 99.36% | Unkown |
| HY-103692 | STX-0119 | Inhibitor | 98.40% | Unkown |
| HY-100602 | HJC0152 | Inhibitor | 99.75% | Unkown |
| HY-121983 | CAY10594 | Inhibitor | 98.64% | Unkown |
| HY-135457 | JMS-053 | Inhibitor | 98.0% | Unkown |
| HY-100453 | HO-3867 | Inhibitor | 99.67% | Unkown |
| HY-N6954 | Garcinone C | Inhibitor | 99.51% | Unkown |
| HY-N2312 | Mogrol | Inhibitor | 99.76% | Unkown |
| HY-N2116 | Ginkgolic acid C17:1 | Inhibitor | 99.80% | Unkown |
| HY-N0885 | Telocinobufagin | Inhibitor | 99.93% | Unkown |
| HY-122258 | NSC-370284 | Inhibitor | 99.27% | Unkown |
| HY-N2963 | Broussonin E | Activator | 98.11% | Unkown |
| HY-148692 | OSM-SMI-10B | Inhibitor | 99.70% | Unkown |
| HY-N0735 | Phellodendrine chloride | Inhibitor | 99.68% | Unkown |
| HY-113573 | Protosappanin A | 99.95% | Unkown | |
| HY-N6953 | Garcinone D | Activator | 99.30% | Unkown |
| HY-103128 | inS3-54A18 | Inhibitor | 99.93% | Unkown |
| HY-N0897 | Corylifol A | Inhibitor | 99.90% | Unkown |
| HY-169360 | SD-436 | Degrader | 98.27% | Unkown |
| HY-129125 | YMU1 | Activator | 99.19% | Unkown |
| HY-N2521 | Tetramethylcurcumin | Inhibitor | 99.91% | Unkown |
| HY-158142 | PROTAC TYK2 degrader-1 | Inhibitor | 99.55% | Unkown |
| HY-N6711 | Equisetin | Inhibitor | 99.40% | Unkown |
| HY-N1356 | Reticuline | Inhibitor | 98.89% | Unkown |
| HY-150538 | STAT3-IN-12 | Inhibitor | 99.87% | Unkown |
| HY-P10201A | Ac-GpYLPQTV-NH2 acetate | Inhibitor | 99.00% | Unkown |
| HY-N0918 | Desmethoxyyangonin | Inhibitor | 99.00% | Unkown |
| HY-P10953 | Fulipiftide | Activator | 99.38% | Unkown |
| HY-12538 | Graveoline | Inhibitor | 99.93% | Unkown |
| HY-164546 | WB436B | Inhibitor | 99.93% | Unkown |
| HY-129138 | Cyanidin 3,5-diglucoside chloride | Inhibitor | 99.44% | Unkown |
| HY-N1410 | Triacetylresveratrol | Inhibitor | 99.11% | Unkown |
| HY-18061 | Ochromycinone | Inhibitor | 99.61% | Unkown |
| HY-12352A | HJC0416 hydrochloride | Inhibitor | 98.68% | Unkown |
| HY-156466 | QL-1200186 | Inhibitor | 99.95% | Unkown |
| HY-N9561 | Vanicoside B | Inhibitor | 99.82% | Unkown |
| HY-151976 | STAT3-IN-15 | Inhibitor | 98.99% | Unkown |
| HY-N1988 | Cucurbitacin IIa | Activator | 99.90% | Unkown |
| HY-P5314 | OK2 | Inhibitor | 99.13% | Unkown |
| HY-N7064 | Iminostilbene | Inhibitor | 99.34% | Unkown |
| HY-136658 | STAT3-IN-48 | Inhibitor | 98.64% | Unkown |
| HY-N7695 | Physalin B | Inhibitor | 97.20% | Unkown |
| HY-124858 | SC99 | Inhibitor | 98.90% | Unkown |
| HY-N3239 | Mulberrofuran G | Inhibitor | 97.86% | Unkown |
| HY-N1407 | Polygalaxanthone III | Activator | 99.28% | Unkown |
| HY-148706 | STAT3-IN-17 | Inhibitor | 98.0% | Unkown |
| HY-124686 | ER-464195-01 | Inhibitor | 99.72% | Unkown |
| HY-179715 | PROTAC JAK1/2 degrader-1 | Inhibitor | 99.47% | Unkown |
| HY-206870 | BP79 | Inhibitor | / | Unkown |
| HY-163526 | STAT3-IN-26 | 96.84% | Unkown | |
| HY-163176 | WB518 | Inhibitor | 96.48% | Unkown |
| HY-120395 | UC-514321 | Inhibitor | 98.0% | Unkown |
| HY-125771S | 1-Stearoyl-sn-glycero-3-phosphocholine-d35 | Inhibitor | 99% | Unkown |
| HY-N0143A | Phlorizin dihydrate | Antagonist | 99.51% | Unkown |
| HY-P2282 | APTSTAT3-9R | Inhibitor | 98.82% | Unkown |
| HY-147187 | MNK8 | Inhibitor | 99.76% | Unkown |
| HY-163502 | PROTAC STAT3 degrader-3 | Degrader | 99.75% | Unkown |
| HY-N2000 | Bellidifolin | Modulator | 99.74% | Unkown |
| HY-122949 | Momordicine I | Inhibitor | 97.0% | Unkown |
| HY-100494 | SH5-07 | Inhibitor | 98.0% | Unkown |
| HY-125170 | Galiellalactone | Inhibitor | 99% | Unkown |
| HY-N0427 | Phellodendrine | Inhibitor | 99.60% | Unkown |
| HY-172946 | SD-2301 | Degrader | / | Unkown |
| HY-100610 | S3I-1757 | Inhibitor | 99.51% | Unkown |
| HY-112391 | SD-1029 | Inhibitor | 88.8% | Unkown |
| HY-120692 | Cyclanoline chloride | Inhibitor | 96.27% | Unkown |
| HY-113509B | 15(R)-Lipoxin A4 | Inhibitor | 98.3% | Unkown |
| HY-N8389 | Globulol | Inhibitor | 99.74% | Unkown |
| HY-N2240 | Eupalinolide K | Inhibitor | 99.20% | Unkown |
| HY-169908 | STAT3-IN-37 | Inhibitor | / | Unkown |
| HY-172767 | STAT3-D11-PROTAC-VHL | Degrader | 96.33% | Unkown |
| HY-125542 | DCZ3301 | Inhibitor | 99.73% | Unkown |
| HY-150251 | SD-91 | Degrader | 97.49% | Unkown |
| HY-117511 | HJC0123 | Inhibitor | 99.06% | Unkown |
| HY-N6651 | Isocryptotanshinone | Inhibitor | ≥98.0% | Unkown |
| HY-177990 | STAT3-IN-52 | Inhibitor | / | Unkown |
| HY-178821 | ROCK2-IN-12 | Inhibitor | 98.02% | Unkown |
| HY-P10201 | Ac-GpYLPQTV-NH2 | Inhibitor | 99.38% | Unkown |
| HY-107595 | SD-1008 | Inhibitor | 99.10% | Unkown |
| HY-182359 | YYSW001 | Inhibitor | / | Unkown |
| HY-144871 | STAT3-IN-8 | Inhibitor | / | Unkown |
| HY-176876 | Glucocorticoid receptor/IL-6-IN-1 | Inhibitor | / | Unkown |
| HY-171656 | G721-0282 | Inhibitor | 99.96% | Unkown |
| HY-182380 | ODZ10117 | Inhibitor | / | Unkown |
| HY-174988 | JAK2-IN-13 | Inhibitor | / | Unkown |
| HY-169403 | NW16 | Inhibitor | / | Unkown |
| HY-162885 | YSY01A | Inhibitor | / | Unkown |
| HY-175634 | ALOX5 stabilizer-1 | Inhibitor | / | Unkown |
| HY-159157 | Anti-inflammatory agent 92 | Inhibitor | / | Unkown |
| HY-180117 | MMP-2/9-IN-2 | Inhibitor | / | Unkown |
| HY-N3913 | Furowanin A | Inhibitor | / | Unkown |
| HY-175320 | PROTAC c-Met degrader-5 | Inhibitor | / | Unkown |
| HY-N13352 | Bufothionine | Inhibitor | / | Unkown |
| HY-122759 | CPA-7 | Inhibitor | / | Unkown |
| HY-175227 | STAT3/NF-κB-IN-1 | Inhibitor | / | Unkown |
| HY-180956 | PROTAC ALK degrader-5 | Inhibitor | / | Unkown |
| HY-W717425 | SC-60 | Inhibitor | / | Unkown |
| HY-175201 | pro-FTY | Inhibitor | / | Unkown |
| HY-161864 | STAT3-IN-29 | Inhibitor | / | Unkown |
| HY-175781 | CHI3L1-IN-4 | Inhibitor | / | Unkown |
| HY-165386 | TU-100 | Inhibitor | / | Unkown |
| HY-184162 | HSP110-IN-1 | Inhibitor | / | Unkown |
| HY-181514 | STAT3-IN-53 | Inhibitor | / | Unkown |
| HY-183272 | PI3K/Akt/mTOR-IN-7 | Inhibitor | / | Unkown |
| HY-150895 | SI-191 | Ligand | / | Unkown |
| HY-12352 | HJC0416 | Inhibitor | / | Unkown |
| HY-180795 | PKM2 activator 11 | Inhibitor | / | Unkown |
| HY-169797 | STAT3-IN-38 | Inhibitor | / | Unkown |
| HY-146666 | STAT3-IN-9 | Inhibitor | / | Unkown |
| HY-180937 | CHI3L1-IN-6 | Inhibitor | / | Unkown |
| HY-138071 | 8α-Tigloyloxyhirsutinolide 13-O-acetate | Inhibitor | 95.0% | Unkown |
| HY-N11501 | 7-epi-Isogarcinol | Inhibitor | / | Unkown |
| HY-12292G | IM-12 (GMP) | Inhibitor | / | Unkown |
| HY-183783 | PROTAC RET Degrader 2 | Inhibitor | / | Unkown |
| HY-149700 | ROCK2-IN-7 | / | Unkown | |
| HY-125718 | MLS-2384 free base | / | Unkown | |
| HY-176555 | Z169667518 | Inhibitor | / | Unkown |
| HY-182288 | YN11 | Inhibitor | / | Unkown |
| HY-164216A | (trans)-STAT6-IN-13 | Modulator | / | Unkown |
| HY-182922 | SD-965 | Degrader | / | Unkown |
| HY-181587 | PDGFRA/CAIX/XII-IN-1 | Inhibitor | 98.10% | Unkown |
| HY-120031 | NSC-368262 | Inhibitor | / | Unkown |
| HY-175848 | NSC 850745 | Inhibitor | / | Unkown |
| HY-184149 | ROCK2-IN-17 | / | Unkown | |
| HY-174428 | PROTAC JAK2 degrader-1 | Inhibitor | / | Unkown |
| HY-175010 | STAT3-IN-44 | Inhibitor | / | Unkown |
| HY-161859 | VEGFR-2/STAT-3-IN-1 | Inhibitor | / | Unkown |
| HY-161351 | STAT3/AKT-IN-1 | Inhibitor | / | Unkown |
| HY-180226 | Apoptosis inducer 55 | Inhibitor | / | Unkown |
| HY-131559 | N-Deacetyl-SI-109-(OEt)2 | / | Unkown | |
| HY-175009 | MRC-G-001 | Inhibitor | / | Unkown |
| HY-184119 | Pabgraminone C | Modulator | / | Unkown |
| HY-164216 | STAT6-IN-13 | Inhibitor | / | Unkown |
| HY-181872 | JAK1-IN-20 | Inhibitor | / | Unkown |
| HY-183307 | mTOR-IN-29 | / | Unkown | |
| HY-151286 | Antitumor agent-73 | Inhibitor | / | Unkown |
| HY-162803 | c-Met-IN-24 | Inhibitor | / | Unkown |
| HY-101021 | Ascochlorin | Inhibitor | / | Unkown |
| HY-N17494 | Crispene E | Inhibitor | / | Unkown |
| HY-183628 | MEAP | Modulator | / | Unkown |
| HY-168178 | Hsp110-STAT3 PPI-IN-2 | Inhibitor | / | Unkown |
| HY-183370 | JAK2/STAT3-IN-2 | Inhibitor | / | Unkown |
| HY-180245 | STAT3-IN-51 | Inhibitor | / | Unkown |
| HY-170947 | Antitumor agent-195 | Inhibitor | / | Unkown |
| HY-176535 | KB-0118 | Inhibitor | / | Unkown |
| HY-129341 | WP1193 | Inhibitor | / | Unkown |
| HY-164445 | STAT3-IN-32 | Inhibitor | / | Unkown |
| HY-181783 | CHI3L1-IN-7 | Inhibitor | / | Unkown |
| HY-115541 | BRD4-IN-41 | / | Unkown | |
| HY-183143 | Lss-11 | Inhibitor | / | Unkown |
| HY-153023 | PROTAC STAT3 degrader-2 | Degrader | / | Unkown |
| HY-182273 | DM243 | Modulator | / | Unkown |
| HY-168893 | K882 | Inhibitor | / | Unkown |
| HY-N13294 | Cernuumolide J | Inhibitor | / | Unkown |
| HY-182510 | NTZ-24 | Inhibitor | / | Unkown |
| HY-146728 | STAT3-IN-10 | Inhibitor | / | Unkown |
| HY-170977 | JAK1/STAT3-IN-1 | Inhibitor | / | Unkown |
| HY-112447 | STAT3-IN-5 | Inhibitor | / | Unkown |
| HY-175013 | CDK6/9-IN-2 | Inhibitor | / | Unkown |
| HY-180922 | EGFR kinase-IN-8 | Inhibitor | / | Unkown |
| HY-174457 | STAT3/CAIX-IN-1 | Inhibitor | / | Unkown |
| HY-181773 | P-gp-IN-36 | Inhibitor | / | Unkown |
| HY-169370 | STAT3 HiBiT degrader 1 | Degrader | / | Unkown |
| HY-183670 | JAK2-IN-21 | Inhibitor | / | Unkown |
| HY-175298 | STAT-3/c-Src-IN-1 | Inhibitor | / | Unkown |
| HY-153858 | PHI-501 | Inhibitor | / | Unkown |
| HY-N16557 | (Rac)-8-Gingerol | Inhibitor | / | Unkown |
| HY-N13338 | Avicin D | Inhibitor | / | Unkown |
| HY-164533 | STAT3-IN-33 | Inhibitor | / | Unkown |
| HY-182274 | DM245 | Inhibitor | / | Unkown |
| HY-170946 | WR-S-462 | Inhibitor | / | Unkown |
| HY-149257 | HAT-SIL-TG-1&AT | Inhibitor | / | Unkown |
| HY-179468 | STAT3-IN-49 | Inhibitor | / | Unkown |
| HY-115438 | AUH-6-96 | Inhibitor | / | Unkown |
| HY-178140 | STAT3-IN-47 | Inhibitor | / | Unkown |
| HY-174386 | STAT3-IN-43 | Inhibitor | / | Unkown |
| HY-168903 | STAT3-IN-41 | Inhibitor | / | Unkown |
| HY-175771 | STAT3-IN-46 | Inhibitor | / | Unkown |
| HY-179243 | S3D5 | Degrader | / | Unkown |
| HY-N0390G | L-Glutamine (GMP) | Inhibitor | / | Unkown |
| HY-171038 | STAT3-IN-39 | Inhibitor | / | Unkown |
| HY-N14323 | Madindoline A | Inhibitor | / | Unkown |
| HY-164521 | PMMB-187 | Inhibitor | / | Unkown |
| HY-119009 | TM-233 | Inhibitor | / | Unkown |
| HY-N4189 | Isocucurbitacin B | Inhibitor | 98.98% | Unkown |
| HY-N16435 | Plumericin | Inhibitor | / | Unkown |
| HY-N20636 | 7α-Morroniside | Inhibitor | / | Unkown |
| HY-107632G | GYY4137 (GMP) | Inhibitor | / | Unkown |
| HY-164425 | ENT-03 | Activator | / | Unkown |
| HY-N8098 | Pulchinenoside E2 | Inhibitor | 99.28% | Unkown |
| HY-183519 | AH057 | / | Unkown | |
| HY-N15201 | Betavulgarin | Inhibitor | / | Unkown |
| HY-124595 | MPT0B098 | / | Unkown | |
| HY-164473 | DETD-35 | Inhibitor | / | Unkown |
| HY-169361 | STAT3 ligand 5 | / | Unkown | |
| HY-N18989 | Cyclo(L-Ile-D-Leu) | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99143 | Anti-Mouse NK1.1 Antibody (PK136) | Inhibitor | 98.57% | Unkown |
| HY-P991218 | Anti-IL11 Antibody (X203) | Inhibitor | 98.53% | Unkown |
| HY-P990212 | Anti-Mouse IL-6 Antibody (MP5-20F3) | Inhibitor | 99.36% | Unkown |
| HY-P990279 | Anti-Mouse CD276/B7-H3 Antibody (MJ18) | Inhibitor | 95.00% | Unkown |
| HY-P990294 | Anti-Mouse CD106/VCAM-1 Antibody (M/K-2.7) | Inhibitor | 95.00% | Unkown |
| HY-P99917 | Eflepedocokin alfa | Activator | ≥99.0% | Unkown |